Elizabeth D. Bacci

1.6k total citations
41 papers, 558 citations indexed

About

Elizabeth D. Bacci is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Rheumatology. According to data from OpenAlex, Elizabeth D. Bacci has authored 41 papers receiving a total of 558 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pulmonary and Respiratory Medicine, 13 papers in Physiology and 9 papers in Rheumatology. Recurrent topics in Elizabeth D. Bacci's work include Asthma and respiratory diseases (10 papers), Respiratory and Cough-Related Research (9 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (7 papers). Elizabeth D. Bacci is often cited by papers focused on Asthma and respiratory diseases (10 papers), Respiratory and Cough-Related Research (9 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (7 papers). Elizabeth D. Bacci collaborates with scholars based in United States, United Kingdom and Denmark. Elizabeth D. Bacci's co-authors include Margaret Vernon, Allison Martin Nguyen, David Muccino, Surinder S. Birring, Carmen La Rosa, Jonathan Schelfhout, Karin S. Coyne, Jiat Ling Poon, Barry J. Make and Catherine A. Meldrum and has published in prestigious journals such as SHILAP Revista de lepidopterología, American Journal of Respiratory and Critical Care Medicine and Journal of Allergy and Clinical Immunology.

In The Last Decade

Elizabeth D. Bacci

39 papers receiving 543 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elizabeth D. Bacci United States 13 310 209 72 50 42 41 558
George Kosmadakis France 14 77 0.2× 136 0.7× 11 0.2× 35 0.7× 38 0.9× 32 651
Jan Hofland Netherlands 16 178 0.6× 47 0.2× 29 0.4× 18 0.4× 25 0.6× 41 802
Isabelle Court‐Fortune France 15 727 2.3× 546 2.6× 45 0.6× 44 0.9× 9 0.2× 34 1.2k
Salvatore Basso Italy 12 417 1.3× 196 0.9× 16 0.2× 12 0.2× 21 0.5× 19 614
A Watson United Kingdom 13 421 1.4× 278 1.3× 17 0.2× 10 0.2× 11 0.3× 21 651
Cathy A. Burnweit United States 19 188 0.6× 32 0.2× 27 0.4× 37 0.7× 14 0.3× 39 856
Leena Jalota United States 13 117 0.4× 89 0.4× 24 0.3× 5 0.1× 7 0.2× 26 1.3k
V. Pinto-Plata Uruguay 2 321 1.0× 170 0.8× 54 0.8× 7 0.1× 15 0.4× 4 622
Tolga E. Dağlı Türkiye 14 115 0.4× 37 0.2× 14 0.2× 35 0.7× 10 0.2× 36 521
Gilbert I. Martin United States 16 381 1.2× 43 0.2× 51 0.7× 6 0.1× 11 0.3× 55 769

Countries citing papers authored by Elizabeth D. Bacci

Since Specialization
Citations

This map shows the geographic impact of Elizabeth D. Bacci's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elizabeth D. Bacci with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elizabeth D. Bacci more than expected).

Fields of papers citing papers by Elizabeth D. Bacci

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elizabeth D. Bacci. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elizabeth D. Bacci. The network helps show where Elizabeth D. Bacci may publish in the future.

Co-authorship network of co-authors of Elizabeth D. Bacci

This figure shows the co-authorship network connecting the top 25 collaborators of Elizabeth D. Bacci. A scholar is included among the top collaborators of Elizabeth D. Bacci based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elizabeth D. Bacci. Elizabeth D. Bacci is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chapple, Christopher R., Matt T. Rosenberg, Elizabeth R. Mueller, et al.. (2023). The patient burden of nocturnal polyuria in the United States: Results from the epidemiology of nocturnal polyuria (EpiNP) study. Neurourology and Urodynamics. 42(3). 573–585. 2 indexed citations
2.
Schelfhout, Jonathan, Allison Martin Nguyen, Surinder S. Birring, et al.. (2022). Validation and Meaningful Change Thresholds for an Objective Cough Frequency Measurement in Chronic Cough. Lung. 200(6). 717–724. 12 indexed citations
3.
Gladman, Dafna D., Laura C. Coates, Joseph Wu, et al.. (2022). Time to response for clinical and patient-reported outcomes in patients with psoriatic arthritis treated with tofacitinib, adalimumab, or placebo. Arthritis Research & Therapy. 24(1). 40–40. 5 indexed citations
4.
Oberdhan, Dorothee, Elizabeth D. Bacci, Jennifer Hill, Andrew Palsgrove, & Asha Hareendran. (2022). Developing a Conceptual Disease Model of Patient Experiences and Identifying Patient-Reported Clinical Outcome Assessments for Use in Trials of Treatments for Focal Onset Seizures. Neuropsychiatric Disease and Treatment. Volume 18. 611–631.
5.
Bacci, Elizabeth D., Rozanne Wilson, Brooke M. Currie, et al.. (2022). Understanding the patient experience of living with notalgia paresthetica: A qualitative interview study. JAAD International. 8. 94–101. 8 indexed citations
6.
Nguyen, Allison Martin, Elizabeth D. Bacci, Margaret Vernon, et al.. (2021). Validation of a visual analog scale for assessing cough severity in patients with chronic cough. Therapeutic Advances in Respiratory Disease. 15. 2663629071–2663629071. 65 indexed citations
7.
Nguyen, Allison Martin, David Muccino, Surinder S. Birring, et al.. (2019). Defining Minimal Clinically Important Differences (MCID) in Chronic Cough: Analyses of Objective Cough Counts from a Phase 2 Randomized Controlled Trial. Journal of Allergy and Clinical Immunology. 143(2). AB169–AB169. 6 indexed citations
8.
Birring, Surinder S., David Muccino, Elizabeth D. Bacci, Margaret Vernon, & Allison Martin Nguyen. (2019). Defining Minimal Clinically Important Differences (MCID) on the Leicester Cough Questionnaire (LCQ): Analyses of a Phase 2 Randomized Controlled Trial in Chronic Cough. Journal of Allergy and Clinical Immunology. 143(2). AB52–AB52. 15 indexed citations
9.
Brooks, Anne, et al.. (2019). Patient Preferences for GLP-1 Receptor Agonist Treatment of Type 2 Diabetes Mellitus in Japan: A Discrete Choice Experiment. Diabetes Therapy. 10(2). 735–749. 16 indexed citations
10.
Leidy, Nancy Kline, Fernando Martínez, Karen G. Malley, et al.. (2018). Can CAPTURE be used to identify undiagnosed patients with mild-to-moderate COPD likely to benefit from treatment?. International Journal of COPD. Volume 13. 1901–1912. 10 indexed citations
11.
Bacci, Elizabeth D., Sean O’Quinn, Nancy Kline Leidy, Lindsey Murray, & Margaret Vernon. (2017). Evaluation of a respiratory symptom diary for clinical studies of idiopathic pulmonary fibrosis. Respiratory Medicine. 134. 130–138. 13 indexed citations
12.
Bacci, Elizabeth D., Amy M. DeLozier, Chen‐Yen Lin, et al.. (2017). Psychometric properties of morning joint stiffness duration and severity measures in patients with moderately to severely active rheumatoid arthritis. Health and Quality of Life Outcomes. 15(1). 239–239. 11 indexed citations
13.
Bacci, Elizabeth D., Amy M. DeLozier, Chen‐Yen Lin, et al.. (2017). Psychometric properties of the single-item measure, severity of worst tiredness, in patients with moderately to severely active rheumatoid arthritis. Health and Quality of Life Outcomes. 15(1). 237–237. 2 indexed citations
14.
Martínez, Fernando J., David M. Mannino, Nancy Kline Leidy, et al.. (2016). A New Approach for Identifying Patients with Undiagnosed Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine. 195(6). 748–756. 75 indexed citations
15.
Gelhorn, Heather L., et al.. (2016). Evaluating preferences for profiles of glucagon-like peptide-1 receptor agonists among injection-naive type 2 diabetes patients in Japan. Patient Preference and Adherence. Volume 10. 1337–1348. 30 indexed citations
16.
Rajagopalan, Krithika, et al.. (2016). The direct and indirect effects of lurasidone monotherapy on functional improvement among patients with bipolar depression: results from a randomized placebo-controlled trial. International Journal of Bipolar Disorders. 4(1). 7–7. 9 indexed citations
17.
Leidy, Nancy Kline, Karen G. Malley, David M. Mannino, et al.. (2015). Insight into Best Variables for COPD Case Identification: A Random Forests Analysis. Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation. 3(1). 406–418. 9 indexed citations
18.
Leidy, Nancy Kline, Katherine Kim, Elizabeth D. Bacci, et al.. (2015). Identifying cases of undiagnosed, clinically significant COPD in primary care: qualitative insight from patients in the target population. npj Primary Care Respiratory Medicine. 25(1). 15024–15024. 12 indexed citations
19.
Calabrese, Joseph R., et al.. (2015). Effect of lurasidone on meaningful change in health-related quality of life in patients with bipolar depression. International Clinical Psychopharmacology. 31(3). 147–154. 5 indexed citations
20.
Han, MeiLan K., Elizabeth D. Bacci, David M. Mannino, et al.. (2014). Identifying Patients with Undiagnosed COPD in Primary Care Settings: Insight from Screening Tools and Epidemiologic Studies. Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation. 2(2). 103–121. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026